A detailed history of Oregon Public Employees Retirement Fund transactions in Eli Lilly & CO stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 67,510 shares of LLY stock, worth $52.6 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
67,510
Previous 68,580 1.56%
Holding current value
$52.6 Million
Previous $62.1 Million 3.67%
% of portfolio
1.18%
Previous 1.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $826,189 - $1.03 Million
-1,070 Reduced 1.56%
67,510 $59.8 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $332,715 - $417,249
459 Added 0.67%
68,580 $62.1 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $36.2 Million - $48.4 Million
-61,090 Reduced 47.28%
68,121 $53 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $25.2 Million - $29.7 Million
-47,992 Reduced 27.08%
129,211 $75.3 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $23.2 Million - $32 Million
-53,428 Reduced 23.17%
177,203 $95.2 Million
Q2 2023

Jul 26, 2023

SELL
$350.74 - $468.98 $19.8 Million - $26.5 Million
-56,553 Reduced 19.69%
230,631 $108 Million
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $1.68 Million - $1.97 Million
-5,413 Reduced 1.85%
287,184 $98.6 Million
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $8.21 Million - $9.56 Million
25,518 Added 9.55%
292,597 $0
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $3.87 Million - $4.41 Million
-13,059 Reduced 4.66%
267,079 $86.4 Million
Q2 2022

Jul 25, 2022

SELL
$278.73 - $327.27 $14.6 Million - $17.2 Million
-52,454 Reduced 15.77%
280,138 $90.8 Million
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $612,540 - $761,232
2,610 Added 0.79%
332,592 $95.2 Million
Q4 2021

Feb 01, 2022

BUY
$224.85 - $279.04 $33.2 Million - $41.3 Million
147,868 Added 81.2%
329,982 $91.1 Million
Q3 2021

Oct 19, 2021

BUY
$221.6 - $272.71 $730,393 - $898,852
3,296 Added 1.84%
182,114 $42.1 Million
Q2 2021

Jul 23, 2021

BUY
$180.55 - $233.54 $20.4 Million - $26.3 Million
112,784 Added 170.8%
178,818 $41 Million
Q1 2021

Apr 20, 2021

BUY
$164.32 - $212.72 $604,040 - $781,958
3,676 Added 5.89%
66,034 $12.3 Million
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $21.2 Million - $28 Million
-162,305 Reduced 72.24%
62,358 $10.5 Million
Q3 2020

Nov 03, 2020

SELL
$146.22 - $169.13 $2.32 Million - $2.69 Million
-15,900 Reduced 6.61%
224,663 $33.3 Million
Q2 2020

Jul 21, 2020

SELL
$136.42 - $164.18 $19.2 Million - $23 Million
-140,387 Reduced 36.85%
240,563 $39.5 Million
Q1 2020

Apr 20, 2020

BUY
$119.05 - $147.35 $17.4 Million - $21.5 Million
145,902 Added 62.07%
380,950 $52.8 Million
Q4 2019

Feb 05, 2020

SELL
$106.92 - $132.43 $7.88 Million - $9.76 Million
-73,692 Reduced 23.87%
235,048 $30.9 Million
Q3 2019

Nov 07, 2019

SELL
$106.79 - $116.16 $1.55 Million - $1.68 Million
-14,491 Reduced 4.48%
308,740 $34.5 Million
Q2 2019

Jul 16, 2019

SELL
$110.79 - $129.32 $11.1 Million - $13 Million
-100,552 Reduced 23.73%
323,231 $35.8 Million
Q1 2019

May 07, 2019

BUY
$111.31 - $131.02 $6.37 Million - $7.49 Million
57,205 Added 15.61%
423,783 $55 Million
Q4 2018

Feb 07, 2019

SELL
$105.9 - $118.64 $4.45 Billion - $4.99 Billion
-42,053,828 Reduced 99.14%
366,578 $42.4 Million
Q4 2018

Feb 05, 2019

BUY
$105.9 - $118.64 $4.47 Billion - $5 Billion
42,182,367 Added 17720.78%
42,420,406 $367,000
Q3 2018

Oct 30, 2018

BUY
$85.86 - $107.31 $115,224 - $144,010
1,342 Added 0.57%
238,039 $25.5 Million
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $10.1 Million - $11.6 Million
133,672 Added 129.75%
236,697 $20.2 Million
Q1 2018

Apr 12, 2018

BUY
$74.21 - $87.6 $15,138 - $17,870
204 Added 0.2%
103,025 $7.97 Million
Q3 2017

Nov 02, 2017

BUY
$77.07 - $85.54 $7.92 Million - $8.8 Million
102,821
102,821 $8.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.